NIT
PACB icon

NumerixS Investment Technologies’s Pacific Biosciences PACB Stock Holding History

NumerixS Investment Technologies’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,000
Closed -$52K – 1273
2019
Q1 		$52K Buy
+7,000
New +$50.6K 0.01% 986
2017
Q2 		– Sell
-7,000
Closed -$36K – 1293
2017
Q1 		$36K Buy
7,000
+1,000
+17% +$4.89K ﹤0.01% 1055
2016
Q4 		$23K Buy
6,000
+800
+15% +$5.81K ﹤0.01% 1029
2016
Q3 		$47K Buy
+5,200
New +$43.5K 0.01% 959

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

NumerixS Investment Technologies's PACB Position: Q2 2019 in Review

NumerixS Investment Technologies sold out of Pacific Biosciences (PACB) in Q2 2019, closing a stake of 7,000 shares — an estimated $52K sold.

NumerixS Investment Technologies first reported a position in PACB in Q3 2016 and held it in 4 quarters. The position peaked at $52K in Q1 2019. 150 funds tracked by Wall St. Rank hold PACB as of Q2 2019.

  • NumerixS Investment Technologies reported no remaining Pacific Biosciences position as of Q2 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 7,000 Pacific Biosciences shares in Q2 2019, an estimated $52K.
  • NumerixS Investment Technologies first reported a position in Pacific Biosciences in Q3 2016 and held it in 4 quarters.
  • NumerixS Investment Technologies's Pacific Biosciences position peaked at $52K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2019.

Based on NumerixS Investment Technologies's 13F filing for Q2 2019, filed 13 Aug 2019.